Skip to content

PHARMACENTRE

Active Public limited companyfounded 1987active for 39 yearsChaussée de Namur 5, 1300 WavreKBO/BCE: BE 0431.307.134 subsidiary of PHARMACIES SERVAIS

Lifetime

20 annual accounts with figures on one time axis, 38 filings since 1988
peak of €247,808 in 2012
€75,069▲ 2.6%
lowest -€298,536 in 2013
€56,429▲ 3.0%
peak of €233,427 in 2012
€78,845▲ 1.8%
€60,055▼ 6.8%
peak of 4.6 FTE in 2009
-not published
Board3 names since 2017
1 director
Owners
100%
Documentsfilings and deeds
11-06-202650 days before the deadline
2025financial year
Merger proposal: to be absorbed by PHARMACIES SERVAIS 26-06Dividend €55,000Cash from €140,816 to €37,902

Key points

from the 2025 annual accounts

Equity

€78,845 from €233,427 in 2012

Equity fell by 66% in 13 years.

Filings

38 annual accounts since 1988
AprilJune31 JulyOctober1990200020102020

The last five annual accounts were filed 50 to 59 days before the end of the period.

Position in the sector

€78,845

Less equity than 80% of companies in retail trade. Sector median €558,236 · 2,454 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,386 companies had the same profile as PHARMACENTRE has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,386 companies, not a prediction for PHARMACENTRE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
  • 100%score equity €7.9m (2025) · annual accounts 2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0431307134
Merger proposal: to be absorbed by PHARMACIES SERVAIS PHARMACIES SERVAIS holds all the shares · Gazette deed
1 director resigning, 1 reappointment Resignation: · Reappointment: PHARMACIES SERVAIS (sole director) · Permanent representative: · General meeting of 19-04-2024 · Gazette deed
Merger proposal: to be absorbed by Pharmacie d'Ohain Pharmacies Servais SRL holds all the shares · Gazette deed
All 55 events

Comparable companies

same main activity, similar in size and age
Company
PHARMACENTRE Wavre €138,900 €75,069 56.8% -
COMMUPHAR Antwerp €136,781 €75,643 -199.4% 1.4
Pharmacie Christine BOVY Charleroi €138,098 €73,135 43.4% -
TOELEN APOTEKERS Halle €118,845 €84,869 66.4% -
PHARMA DANCKAERT Antwerp €132,287 €69,605 26.4% 0.8
Apotheek Bellens Lokeren €195,155 €76,004 8.8% -
LONDON PHARMA Ixelles €161,051 €95,778 42.8% -

These companies have the same main activity as PHARMACENTRE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €119,000 and €195,000, founded between 1978 and 1997.

Official details

Source: KBO
Status
Active since 04-06-1987Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.030.651.5471410 Waterloo, since 23-06-1987
Financial year end
31 December
Peppol
Reachable since 21-10-2026
Company details

Annual accounts 2025

≈ €360,000estimated
€138,900▼ 2.1%
Filing
Filed on 11-06-2026, 50 days before the end of the filing period
Financials

Insights on PHARMACENTRE

PHARMACENTRE has existed since 1987. The gross margin fell from €187,180 in 2006 to €75,069 in 2025.

PHARMACIES SERVAIS holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMACENTRE

What is the company number of PHARMACENTRE?
The company number of PHARMACENTRE is 0431.307.134. The VAT number is the same number with BE in front: BE 0431.307.134.
Where is PHARMACENTRE based?
The registered office is at Chaussée de Namur 5, 1300 Wavre.Company details
What does PHARMACENTRE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACENTRE?
PHARMACENTRE is a public limited company (NV).
When was PHARMACENTRE founded?
PHARMACENTRE was founded on 04-06-1987.
Is PHARMACENTRE still active?
Yes, PHARMACENTRE is an active enterprise in the KBO register.
What is the turnover of PHARMACENTRE?
The turnover in financial year 2025 is ≈ €360,000. This figure is estimated from the gross margin of €75,069 and 76 comparable companies (NACE 477). It probably lies between €180,000 and €530,000.Financials
Is PHARMACENTRE profitable?
In financial year 2025, PHARMACENTRE made a profit of €56,429.
Where can I find the annual accounts of PHARMACENTRE?
PHARMACENTRE filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACENTRE due?
PHARMACENTRE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.